Details

Autor(en) / Beteiligte

• Perin, G
• Shaw, M
• Pingle, V
• Palmer, K
• Al-Rawi, O
• Ridgway, T
• Pousios, D
• Modi, P

Titel

Use of an automated knot fastener shortens operative times in minimally invasive mitral valve repair

Ist Teil von

• Annals of the Royal College of Surgeons of England, 2019-09, Vol.101 (7), p.522-528

Ort / Verlag

England

Erscheinungsjahr

2019

Quelle

MEDLINE

Beschreibungen/Notizen

• Longer durations of cardiopulmonary bypass and aortic cross clamp are associated with increased morbidity and mortality. Little is known about the effect of automated knot fasteners (Cor-Knot®) in minimally invasive mitral valve repair on operative times and outcomes. The aim of this study was to evaluate whether these devices shortened cardiopulmonary bypass and aortic cross clamp times and whether this impacted on postoperative outcomes. All patients undergoing isolated minimally invasive mitral valve repair by a single surgeon between March 2011 and March 2016 were included ( = 108). Two cohorts were created based on the use ( = 52) or non-use ( = 56) of an automated knot fastener. Data concerning intraoperative variables and postoperative outcomes were collected and compared. Preoperative demographics were well matched between groups with no significant difference in logistic Euroscore (manual vs automated: median 3.1, interquartile range, IQR, 2.1-5.5, vs 5.4, IQR 2.2-8.3; = 0.07, respectively). Comparing manually tied knots to an automated fastener, cardiopulmonary bypass and aortic cross clamp times were significantly shorter in the automated group (cardiopulmonary bypass: median 200 minutes, IQR 180-227, vs 165 minutes (IQR 145-189 minutes), < 0.001; aortic cross clamp 134 minutes (IQR 121-150 minutes) vs 111 minutes (IQR 91-137 minutes), < 0.001, respectively). There was no mortality and no strokes, nor were there any differences in postoperative outcomes including reoperation for bleeding, renal failure, intensive care or hospital stay. The use of an automated knot fastener significantly reduces cardiopulmonary bypass and aortic cross clamp times in minimally invasive mitral valve repair but this does not translate into an improved clinical outcome.